Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies.
Yang RK, Qing Y, Jelloul FZ, Routbort MJ, Wang P, Shaw K, Zhang J, Lee J, Medeiros LJ, Kopetz S, Tetzlaff MT, Broaddus RR.
Yang RK, et al.
Oncotarget. 2020 Feb 11;11(6):600-618. doi: 10.18632/oncotarget.27466. eCollection 2020 Feb 11.
Oncotarget. 2020.
PMID: 32110280
Free PMC article.
Multivariate regression analysis including the two variables of tumor mutation burden (TMB) and ICB, and their interaction term, showed favorable survival associated with ICB, unfavorable survival associated with TMB without ICB treatment, and improved outcome with increas …
Multivariate regression analysis including the two variables of tumor mutation burden (TMB) and ICB, and their interaction term, show …